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Can the CDC's Get Smart program and the Use of a Decision Tree Model alter Clinician
Guideline Adherence for ABRS and AVRS?
Background
Each day, clinicians work with patients to provide the necessary care to improve
individuals’ health conditions. Clinicians use vast amounts of information to formulate decisions
to treat patients. However, clinical practice guidelines are developed to help clinicians
systematically treat a particular disease process, especially in the use of appropriately prescribing
antibiotic therapies. Clinical practice guidelines are in place to help clinicians provide a
standardized process of care based on current research that leads to positive patient outcomes.
According to Darrat, Yaremchuk, Payne, & Nelson (2014), utilization of clinical practice
guidelines are intended to improve quality of care and decrease ineffective therapeutic practices.
Such practices include decreased antibiotic use, decreased healthcare-associated infections,
decreased length of stays, and a decrease in a prevalence of antibiotic bacterial resistance
(Laximinarayan et al., 2013). Friedman et al., (2008) reported that consensus from clinicians
combined with changes in behaviors and attitudes are necessities for successful implementation
of clinical practice guidelines. Another benefit of appropriate application of clinical guidelines is
that patients who receive the appropriate therapeutic treatments experience fewer side effects and
increased patient satisfaction.
As an important piece of guideline adherence, providers should advise patients to use
supportive treatments such as antihistamines, decongestants, corticosteroid nasal sprays, and
nasal washings; as adjunctive treatments for ABRS and AVRS. Treatment guidelines that
advocate prevention of antibiotic over-prescribing will also promote “watchful waiting” and

supportive therapies with careful follow-up as regimens for patients with viral infections
(Rosenfeld et al., 2015).
Particular treatment guidelines factor in timing of symptoms as a way to assist providers
to diagnose ABRS and AVRS. For example, if a patient presents with a set of symptoms that
have been ongoing for ‘x’ number of days, then the provider can apply the treatment guideline to
the patient’s symptoms and timing of the symptoms to provide an appropriate diagnosis and
treatment plan. In diagnosing a viral sinus infection, the literature used the term acute viral
rhinosinusitis (AVRS) to include upper respiratory infection (URI), viral syndrome, and viral
infection/common cold. For a bacterial infection, the literature used the term acute bacterial
rhinosinusitis (ABRS) which is associated with sinusitis and the specific sinus sites (maxillary,
frontal, ethmoid, and sphenoid).
Chow et al. (2012) developed a decision tree tool that examined acute bacterial
rhinosinusitis (ABRS) symptoms with a timing component (symptoms for 3-4 days, 5-10 days,
and >10 days). If symptomatic for 3-4 days, the patient’s symptoms had to include a fever >
102F and purulent nasal drainage before diagnosis as ABRS was warranted. For a patient with
symptoms for 5-10 days, her symptoms might be classified as “worsening” and the provider
would have to ask: “Did your symptoms improve and then get worse?” This ‘worsening’ state is
typically known as “double sickening.” If the patient stated ‘yes’ to the critical question, then the
patient would be diagnosed with ABRS correctly. Lastly, if symptomatic for greater than 10
days, then the condition is known as “persistent” and the provider has to ask: “Are your
symptoms improving?” Most patients who are seeking treatment at this stage are not improving
and would be diagnosed with ABRS.

Despite the strong support for utilizing clinical practice guidelines, guideline adherence
may be eroded by clinicians’ lack of familiarity with the guideline, inconsistent application,
perception of interference with individualized care, or disagreement (File & Hadley, 2002; Gill
et al., 2006). Typically, guidelines are vetted through rigorous systematic reviews, professional
organizations and clinical experts. However, guidelines are guides -not rules- that are to be
applied in conjunction with the clinician’s experience and patient preference. One challenge of
guideline dissemination is creating sufficient adherence so that deviations from the guideline
recommendations are exceptions (Laximinarayan et al., 2013).
Laximinarayan et al., (2013) stated that physicians are influenced by their peers and
perceived demands from patients. Providers can be influenced by colleagues and their
prescribing trends. Patient perception and expectation for certain treatments can also influence
how a physician will prescribe a certain medication. This peer and patient influence might be a
barrier to treatment guidelines adoption. With the expansion of consumer-driven healthcare and
more knowledgeable patients, many patients come to a provider with preconceived notions of
diagnosis and needed treatment. More patients, who have investigated their potential diagnosis
and treatment, have led many providers to prescribe unnecessary antibiotics for illnesses, due to
busy office schedules and desire to avoid unpleasant conflict with patients.
Imprudent and hasty prescription of antibiotics for self-limited illnesses has led to the
overgrowth of drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus and
Clostridium difficile (Hickner et al., 2001). Patients who are inappropriately treated with
antibiotics have developed drug resistant bacteria, increased medical cost, increased time away
from work, and increased time away from school (File & Hadley, 2002; Zoorob et al, 2012).

Utilizing clinical practice guidelines could help control the number of unnecessary antibiotic
prescriptions written. As previously stated, utilization and adherence of treatment guidelines will
lead to improved patient outcomes. Potential benefits of adherence to clinical guidelines could
include decreased costs to the healthcare system and to patients, reduction in antibiotic resistant
bacteria, and reduction in antibiotic overprescribing.
Rhinosinusitis is a common medical condition that affects approximately 1 in 8 adults in
the United States accounting for over 30 million annual diagnoses (Rosenfeld et al., 2015).
According to the authors, 20% of all antibiotics prescribed are for the treatment of sinusitis,
which makes sinusitis the fifth most common diagnosis requiring antibiotic therapy. Research
shows that despite the availability of national treatment guidelines for acute bacterial
rhinosinusitis (ABRS) and acute viral rhinosinusitis (AVRS), antibiotics are still being
overprescribed and continued variability in treatment practices still exist(Rosenfeld et al., 2015).
According to Rosenfeld (2015), national ambulatory data statistics between 2006-2010
revealed that rhinosinusitis accounted for more outpatient antibiotic prescriptions than any other
diagnosis. The CDC specifies that a patient who presents with symptoms less than 7 days in
duration is unlikely to have a bacterial infection. Supportive treatments, such as decongestants,
antihistamines, and nasal washings could provide sufficient therapy for patients with these
symptoms (Chow et al., 2012). Publications on rhinosinusitis first appeared in the 1970’s. Many
articles discuss the origin of sinusitis and appropriate treatments. An article written by Hamory,
Sande, Sydnor, Seale, and Gwaltney (1979) discussed the origin and antimicrobial therapy for
acute maxillary sinusitis. They studied 81 patients with symptoms of acute sinusitis, who
underwent direct needle puncture and aspiration of the maxillary sinuses. Streptococcus
pneumoniae and Haemophilus influenza accounted for 64% of the bacterial strains identified.

The World Health Organization (WHO) affirmed that the use of clinical practice
guidelines is at the core of the managerial strategy in every health care system to improve
diagnosis and therapy (WHO, 2001). The authors believe that in order for guidelines to be
effective in a clinical practice they must be actively disseminated. Some strategies discussed to
facilitate dissemination and adoption included local involvement of end-users in the development
process, presentation of key elements in a simple algorithm or protocol, and dissemination in a
multi-component program. The WHO’s program would include innovative education and
monitoring protocols that could impact adherence and reinforcement.
Alweis, Greco, Wasser, and Wenderoth (2014) examined enhancing the knowledge of
providers and residents at a specific teaching facility. They implemented three small scale,
bundled interventions: (1) guidelines sent to each provider by email; (2) CDC Get Smart posters
placed in examination rooms; and (3) provider education on the CDC Get Smart: Know When
Antibiotics Work prescription pads. The CDC’s Get Smart Program: Know How Antibiotics
Work was implemented into the practice not only to provide the patients with some foundational
information in the waiting rooms and in the exam rooms, but also to offer clinicians knowledge
and resources.
In previous bodies of work, researchers have not evaluated clinicians’ treatment of AVRS
and ABRS by examining the impact of a national education toolkit and a decision tree tool. It is
the intent of this scholarly project to determine whether an educational program based on a
national education toolkit plus a decision tree tool offered to health care providers in a Middle
Tennessee walk-in clinic, promoted an increase in treatment guideline adherence when
diagnosing and treating acute bacterial rhinosinusitis and acute viral rhinosinusitis.

Theoretical Framework
The Promoting Action on Research Implementation in Health Services framework
(PARiHS) is a strategy for successfully implementing evidence into practice. It was initially
published by Kitson and colleagues as an unnamed framework in 1998 focusing on practice
improvement and guideline implementation efforts. The framework was refined and published in
2002. After additional evidence review, the developers created and published three central
elements in 2004. Finally, in 2008, a two-step process was developed for PARiHS (Helfrich et
al., 2010).
PARiHS is comprised of three main elements: evidence (E), which are sources of
knowledge as perceived by multiple stakeholders; context (C), which is the quality of the
environment where the research will be conducted; and facilitation (F), which are the techniques
people utilize to support to change, i.e. attitudes, behaviors, skills, and/or thinking (Helfrich et
al., 2010).
There are three or four sub-elements for each of the main elements that further explain
and support each of the elements. Within the element ‘evidence’, the four sub-elements include
research evidence from studies and clinical practice guidelines, formal experiments; clinical
experience/professional knowledge; patient preferences and experiences; and project
evaluation/quality improvement initiatives. For the element ‘context’, the sub-elements include
receptive context/environment; organizational culture, leadership, and evaluation. Lastly, for the
element ‘facilitation’, the sub-elements comprise purpose, role of the facilitator, and the
skills/attributes of the facilitator (Helfrich et al., 2010).
Since its creation, the PARiHS framework has been utilized many times or cited in
literature by many researchers. According to Ullrich, Sahay, and Stetler (2014), it has rich

empirical support and strength for implementation projects that cannot be denied. However,
because many of these researchers have not operationalized all of the key components of the
framework, research is limited on how well this framework works in its entirety. One article
demonstrated PARiHS’ use in a quasi-experimental research design study. Sving, Hogman,
Mamhidir, and Gunningberg (2014) examined knowledge and attitudes of nurses regarding
pressure ulcer prevention in a hospital setting. The intervention was based on the PARiHS
framework and included a multi-disciplinary team, training, and repeat quality measures.
The PARiHS framework was prospectively applied to this scholarly project because of its
three main elements. The evidence included the clinical practice guidelines, CDC Get Smart
program, and the adjusted decision tree tool that the project leader used as the foundation for
provider education. The context of the project included support from organizational leadership,
receptive environment to learning, and a known clinical environment to the project leader. The
facilitation aspect contained the implementation of the project, Get Smart program materials, and
the decision tree tool. Sving, Hogman, Mamhidir, & Gunningberg (2014) stated that successful
implementation occurs when evidence was expansive, context/environment was receptive to
change, and the process of change was facilitated appropriately.
Methods
Participants
The participants included eight health care providers (7 family nurse practitioners and 1
physician assistant) employed by a walk-in clinic in Middle Tennessee. The convenience sample
included providers who rotated between three locations. Exclusion was determined if they were
not an employee of the specified clinic.

Materials
Pre- and post- questionnaires were completed during the educational luncheon (See
appendices A & B). The questionnaires were adapted from Alweis et al. (2014). The
questionnaires remained anonymous and were reviewed for responses. The educational luncheon
session was based on the Infectious Diseases Society of America (IDSA) treatment guideline on
rhinosinusitis (Chow et al., 2012), information on the decision tree model the project leader
created, discussion on most frequent codes used for diagnoses in the clinic, and the CDC’s Get
Smart program documents. The program documents consisted of handouts, pamphlets, patient
teaching sheets, posters, viral prescription pads, and antibiotic teaching sheets. The information
was presented in a PowerPoint format and allowed time for questions.
The CDC Get Smart program is a free educational program for providers and patients.
The CDC’s Get Smart program provides documents for laypersons and providers on how
antibiotics work for particular well-known illnesses and helps to decrease overprescribing of
antibiotics. The educational tools within the program allow for increased knowledge of common
diseases seen in primary care linked to antibiotic over-prescription. The tools provide
knowledge, not only on the diseases, but also recommended treatment regimens including nonantibiotic options.
These tools provide an excellent way to educate the public on the differences between
viral and bacterial infections, but also when it is necessary to prescribe an antibiotic. Additional
information about the Get Smart Program is available at:
http://www.cdc.gov/getsmart/community/about/should-know.html. The decision tree tool was a
modification of Chow et al. (2012) algorithm using patient symptoms and symptom timing to

diagnosis and manages ABRS. The project leader adapted the published algorithm to incorporate
a viral component to assist providers in diagnosing AVRS. (See Appendices C, D, E, F, G & I).
Design
The project was a quasi-experimental one-group, pre-post without randomization design.
This design was chosen to answer questions regarding the pre- and post-treatment observed
behavior of the participants. Three bundled small-scale interventions were implemented to
determine the impact on treatment guideline adherence for acute bacterial and viral
rhinosinusitis. The independent variables were the CDC’s Get Smart Program, the educational
luncheon curriculum, and the decision tree tool. The dependent variables in this project were
provider knowledge and providers’ treatment of AVRS and ABRS. Change in knowledge was
measured through the pre- and post-education questionnaires. Providers’ treatment of AVRS and
ABRS was measured through chart reviews. Description of these items will be further discussed
in the Procedure section.
Procedure
The 45-minute educational curriculum was provided at a luncheon to the providers in
September 2015. Four clinicians were able to attend the initial session, plus administrative and
nursing staff. The four participants completed consent and pre-test questionnaires. The
questionnaire asked the providers questions regarding their personal experience and perceptions
on treatment guidelines. The program curriculum included a discussion and review of the IDSA
guideline on rhinosinusitis, education on utilizing the decision tree tool, and education on the
CDC’s Get Smart: Know When Antibiotics Work program.
The providers were shown all of the components of the Get Smart program (posters,
handouts, brochures, fliers, teaching sheets, and viral prescription pad given to patients if

diagnosed with AVRS). Following the completion of the educational curriculum, the providers
completed a post-questionnaire to evaluate change in his/her knowledge and if they found the
treatment guidelines and decision tree tool beneficial. The four participants who were not able to
attend the group educational session received education on four different occasions because of
schedule conflicts.
Using the electronic medical record (EMR) system (Touchworks), an IT associate
compiled the charts by dates of visit, diagnoses, medical record numbers, providers participating
in the educational sessions, and clinic location in a spreadsheet. This information allowed the
project leader to analyze treatment patterns of the providers who had the opportunity to
participate in the educational sessions.
Data collection occurred from October through December, 2015. Charts were viewed by
medical record number (MRN). Once identified by the MRN, the project leader viewed the HPI
for symptoms, diagnoses, and plan for treatment regimen. Symptoms identified included nasal
congestion, sore throat, fever, cough, and/or nasal drainage. Timing of symptoms identified was
grouped as: 1-2 days, 3-4 days, 5-10 days, and > 10 days. Diagnoses included ABRS or AVRS.
ABRS was coded as sinusitis. AVRS was coded as viral syndrome or URI. Pediatric cases (age <
17) and diagnoses other than sinusitis, upper respiratory infection, and viral syndrome were
excluded.
Antibiotic treatments included were Augmentin 875 mg, Augmentin 2000 mg,
Doxycycline 100 mg, and/or Levofloxacin 500 mg. Supportive therapies that were identified
included antihistamines, decongestants, nasal washings, and/or corticosteroid nasal sprays.
Teaching modalities that were identified and included were CDC viral prescription pad,
antibiotic teaching sheet, and/or follow-up recommendations. Each symptom, timing of

symptom, diagnosis, prescriptive modality, supportive therapy, and teaching modality was coded
as a dichotomous variable (yes/no), when identified in the chart.
Results
There were 8 providers who participated in the study; 7 were nurse practitioners and 1
was a physician assistant. At the educational luncheon 4 participants received the education;
which included four providers (3 NP, 1 PA). Four other providers received their education at
other times due to competing priorities (Table 1). A total of 114 charts were reviewed, with a
retrospective chart review on 65 (57%) charts before the educational session and 49 (43%) charts
reviewed after the educational session. The 114 charts reviewed included 56 ABRS diagnoses
and 58 AVRS diagnoses (Table 2).
The project leader compared whether the training had any influence on the providers’
ability to correctly diagnose ABRS and AVRS. The percentage of records with a likely diagnosis
of ABRS or AVRS prior to implementation of the educational session was 49% (n = 32) for
ABRS and 51% (n = 33) for AVRS. A Chi-square test was performed and this measure showed
no statistical difference during the post-training phase of the study [n = 24(49%), 25(51%); (p =
1.000)] (Figure 1).
Nasal drainage and fever are primary symptoms that patients present when diagnosed
with ABRS or AVRS. It is important to note that these symptoms present in ABRS during the 34 days of duration. If not diagnosed with ABRS, then it is presumed the illness is AVRS. Based
on agreement with the Chow et al. (2012) guidelines, among patients who present to the clinic
with symptoms within 1-2 days of duration, the providers diagnosed 2 cases of ABRS (6%). At
1-2 days of symptom duration, 94% of the cases were diagnosed as AVRS (n = 31). A Chi-

square test was performed and there was a statistical significance and a relationship found
between timing of symptoms and diagnoses (p = 0.000).
Providers diagnosed 22 cases of ABRS (59.5%) versus 15 cases of AVRS (40.5%)
appropriately based on the guidelines, within 3-4 days of duration. A Chi-square test was
performed, which resulted in a statistically significant relationship found between timing of
symptoms and diagnoses (p = 0.000). In addition, providers diagnosed 17 cases of ABRS (61%)
when compared to 11 cases of AVRS (39%), when patients presented with symptoms within 510 days duration. As previously noted, a Chi-square test was performed and there was a
statistical significant relationship between timing of symptoms and diagnoses (p = 0.000). At the
3-4 and 5-10 day symptom range, when comparing the diagnoses of AVRS and ABRS; there was
a fairly even split between the two diagnostic categories.
Lastly, patients who presented with symptoms to the clinic at > 10 days of duration were
appropriately diagnosed with ABRS 94% of the time (15 of 16 cases). A Chi-square test was
performed on the data. Among providers, there was a statistical significance in the relationship
between timing of symptoms > 10 days of duration and significance (p = 0.000) (Figure 2). Of
note, it was determined that providers did not ask and/or document the discriminating questions
that would allow for the distinction of whether the provider was applying the guideline, when
patients presented with symptom duration of 5-10 days and >10 days. Additionally, the project
compared whether there was a change in how supportive therapies were recommended for
AVRS after the educational session. The percentage of providers who documented supportive
treatments prior to the implementation of the intervention was 29%. Participants’
recommendation of supportive therapies after the educational session was unchanged based on a
Chi-square test (n =19; p = .320) (Figure 3).

Discussion
In this study, the providers appropriately diagnosed and treated patients with symptoms
lasting 1-2 days and > 10 days consistently. No antibiotics were prescribed when patients were
diagnosed with AVRS at 1-2 days of symptoms. However, if the patient was diagnosed with
ABRS, antibiotic therapy was consistent with the guidelines When patients reported symptoms
of 3-4 and 5-10 days in duration, charts showed variability in clinician diagnosis and treatment of
AVRS and ABRS. Possible causes of the variability could be clinicians’ experience with the
guidelines, patients’ symptoms and patients’ presentation at time of visit.
Documentation of supportive therapies was inconsistent without differentiation for
diagnosis or symptom duration. Of note, providers’ knowledge of guideline adherence was not
tested for change after implementation of program components, such as the decision tree tool and
the CDC Get Smart Program. Due to a small convenience sample, the questionnaires’
quantitative results from the clinicians were not utilized and a change in knowledge was
undetermined before or after the educational session.
Qualitative data gathered through questionnaires suggested a positive response to both
the decision tree tool and the CDC Get Smart program items distributed. Although the providers
found the tool and program beneficial, there was no documented use of these items in the
electronic medical record. A possible resolution would be to embed the tools in the electronic
chart for ease of use, visualization, application, and documentation.
For symptoms ranging from 5-10 and > 10 days, a provider would need to ask a
discriminating question, (such as “Did your symptoms improve and then get worse?” or “Are
your symptoms improving?”) and document this information, along with the patient’s current
symptoms in order for to comply with the guidelines. However, the discriminating question and

documentation were missing from the reviewed charts both before and after the educational
session. Because the information was absent from the chart, one would have to consider if the
providers used the discriminating questions in their diagnostic reasoning. The conclusion might
demonstrate a lack of guideline/decision tree utilization.
Additional research is needed to determine the cause of variability in treatment for those
patients with symptoms lasting 3-4 and 5-10 days. Likewise, further education is warranted for
providers to become more knowledgeable in the use of the guideline, which could result in the
providers probing for additional information and documenting appropriately. Although the
project leader believes that education is a valuable and necessary component for supporting
positive practice change, the educational session and CDC materials were not sufficient to create
change in this project. For those interested in promoting guidelines adherence, consideration of
strategies in addition to an education session and the CDC materials may lead to improved
likelihood of provider behavior change.
Conclusion
Guideline adherence of providers can vary, depending on knowledge of the present
illness and practice styles. Most providers are guided by their clinical expertise and some other
area of influence. The education session, the modified decision tool and the CDC Program
materials showed no difference on the clinicians’ practice behavior. Similarly, the study revealed
variations in how clinicians are treating patients who seek treatment with 3-10 days of URI
symptoms. Additional strategies, such as discussion or further research, are needed to assist
providers in their ability to discriminate between these symptoms for improved diagnoses of
ABRS and AVRS.

In this project, it was shown that education of the provider on guidelines did not show
any statistical difference in their practice behavior. More research and discussion are needed in
this specific subject to enhance the providers’ knowledge on the appropriate tools and resources
used to discriminate between viral and bacterial illness. Additional research is needed to identify
other modes of education delivery that can lead to improved diagnoses of ABRS and AVRS.
Ultimately, this improvement will lead to additional understanding that will aid in decreasing the
improper use of antibiotics.
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Appendix A
Pre-Questionnaire for Providers on Guideline Adherence

1.) How many years has it been since you completed your original certification or most
recent recertification?
a. 0-5 years
b. 6-10 years
c. 11-15 years
d. More than 15 years
2.) When was the last time you went to an educational conference of any type?
a. 0-1 years
b. 2-4 years
c. 5-7 years
d. 8 or more years
3.) When was the last time that you went to an educational conference that covered a topic
dealing with allergies and/or sinusitis?
a. 0-1 years
b. 2-4 years
c. 5-7 years
d. 8 or more years
4.) For the diagnosis of acute bacterial rhinosinusitis, how well do you believe that you know
the treatment guidelines?
a. Not at all
b. Mildly well

c. Moderately well
d. Very well
5.) For the diagnosis of acute bacterial rhinosinusitis, how often do you believe you prescribe
antibiotics in a guideline adherent manner?
a. 0-25% of the time
b. 26-50% of the time
c. 51-75% of the time
d. 76-100% of the time
6.) For each of the following factors that might influence your decision to prescribe
antibiotics, please indicate the importance of each factor:
a. Patient desires antibiotics
i. Not at all important
ii. Mildly important
iii. Moderately important
iv. Very important
b. Uncertainty in diagnosis
v. Not at all important
vi. Mildly important
vii. Moderately important
viii. Very important
c. Clinician lack of knowledge in treatment guidelines
ix. Not at all important
x. Mildly important

xi. Moderately important
xii. Very important
d.

Lack of clinical decision support tools
xiii. Not at all important
xiv. Mildly important
xv. Moderately important
xvi. Very important

Appendix B
Post-Questionnaire for Providers on Guideline Adherence

7.) How many years has it been since you completed your original certification or most
recent recertification?
a. 0-5 years
b. 6-10 years
c. 11-15 years
d. More than 15 years
8.) For the diagnosis of acute bacterial rhinosinusitis, how well do you believe that you know
the treatment guidelines?
a. Not at all
b. Mildly well
c. Moderately well
d. Very well
9.) For the diagnosis of acute bacterial rhinosinusitis, how often do you believe you prescribe
antibiotics in a guideline adherent manner?
a. 0-25% of the time
b. 26-50% of the time
c. 51-75% of the time
d. 76-100% of the time

10.)

For each of the following factors that might influence your decision to prescribe

antibiotics, please indicate the importance of each factor:
a. Patient desires antibiotics
i. Not at all important
ii. Mildly important
iii. Moderately important
iv. Very important
b. Uncertainty in diagnosis
i. Not at all important
ii. Mildly important
iii. Moderately important
iv. Very important
c. Clinician lack of knowledge in treatment guidelines
i. Not at all important
ii. Mildly important
iii. Moderately important
iv. Very important
d. Lack of clinical decision support tools
i. Not at all important
ii. Mildly important
iii. Moderately important
iv. Very important

11.)

During this educational luncheon, did you learn any new information learned

about national treatment guidelines for acute bacterial rhinosinusitis?
a. Yes
b. No
c. Somewhat
12.)

Due to this information, will your prescribing habits change?
a. Definitely
b. Maybe
c. No
d. I don’t know

13.)

Will you use the Decision Tree tool in your clinical practice?
a. Definitely
b. Maybe
c. No
d. I don’t know
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Table 1.
Demographics: Providers
Nurse Practitioners
7

Physician Assistants
1

Table 2.
Demographics: Total Charts Before/After Training
Before Educational Session
65 (57%)

After Educational Session
49 (43%)

Table 3.
Likely Diagnosis cases Before/After Training

ABRS (n = 56)
AVRS (n = 58)
(n = 114; p = 1.000)

Before Training
57.1% (n=32)
56.9% (n=33)

After Training
42.9% (n=24)
43.1% (n=25)

Figure 1.
Likely Diagnoses Before and After Educational Session

Correct Diagnoses Before and After Educational Session
52%

Before Educational
Session, 51%

After Educational
Session, 51%

51%
51%
50%

50% Before Educational
Session, 49%
49%

After Educational
Session, 49%

49%
48%
Before Educational
Session

After Educational Session
ABRS

ABRS (n = 32, 24)
AVRS (n = 33, 25)
(p = 1.000)

AVRS

Table 4.
# of cases: Timing of Symptoms and Diagnoses of AVRS and ABRS
1-2 days
2
31

ABRS
AVRS

3-4 days
22
15

➢ 10 days
15
1

5-10 days
17
11

Figure 2.
Timing of symptoms and diagnosis of ABRS and AVRS

Timing of Symptoms vs. Diagnoses
100

1-2 days, 93.9

> 10 days, 93.8

90
80
70

5-10 days, 60.7

3-4 days, 59.5

60
50

3-4 days, 40.5

5-10 days, 39.3

40
30

20
10

> 10 days, 6.3

1-2 days, 6.1

0
1-2 days

3-4 days

5-10 days
ABRS

(n = 114; p = 0.000)

AVRS

> 10 days

Figure 3.
Supportive treatment recommendations before and after educational session

Supportive Treatment recommendations
before and after educational session
40%
35%
30%
25%
20%

Supportive Treatment
Recommendations

15%
10%
5%

0%
Before Educational Session

(n = 19, 19; p = .320)

After Educational Session

